Dai ichi Life Insurance Company Ltd increased its holdings in MSCI Inc. (NYSE:MSCI – Free Report) by 548.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,783 shares of the technology company’s stock after buying an additional 3,200 shares during the period. Dai ichi Life Insurance Company Ltd’s holdings in MSCI were worth $2,205,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in MSCI. Frank Rimerman Advisors LLC lifted its holdings in shares of MSCI by 0.9% in the third quarter. Frank Rimerman Advisors LLC now owns 1,968 shares of the technology company’s stock valued at $1,147,000 after purchasing an additional 17 shares in the last quarter. Conning Inc. grew its holdings in MSCI by 4.1% during the 2nd quarter. Conning Inc. now owns 479 shares of the technology company’s stock valued at $231,000 after buying an additional 19 shares during the last quarter. Capital Advisors Ltd. LLC grew its holdings in MSCI by 3.8% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 542 shares of the technology company’s stock valued at $261,000 after buying an additional 20 shares during the last quarter. Concurrent Investment Advisors LLC increased its position in MSCI by 5.0% during the second quarter. Concurrent Investment Advisors LLC now owns 423 shares of the technology company’s stock worth $204,000 after buying an additional 20 shares in the last quarter. Finally, Planning Capital Management Corp raised its holdings in shares of MSCI by 35.1% in the third quarter. Planning Capital Management Corp now owns 77 shares of the technology company’s stock worth $45,000 after acquiring an additional 20 shares during the last quarter. 89.97% of the stock is owned by institutional investors and hedge funds.
MSCI Price Performance
Shares of NYSE:MSCI opened at $605.16 on Thursday. The business has a 50-day moving average of $588.89 and a two-hundred day moving average of $544.51. The firm has a market capitalization of $47.43 billion, a PE ratio of 39.73, a P/E/G ratio of 3.08 and a beta of 1.11. MSCI Inc. has a 12 month low of $439.95 and a 12 month high of $631.70.
MSCI Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be issued a dividend of $1.60 per share. The ex-dividend date is Friday, November 15th. This represents a $6.40 annualized dividend and a dividend yield of 1.06%. MSCI’s payout ratio is 42.02%.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the company. Wells Fargo & Company increased their price objective on MSCI from $570.00 to $600.00 and gave the company an “equal weight” rating in a research note on Friday, October 11th. UBS Group lowered their price target on shares of MSCI from $695.00 to $680.00 and set a “buy” rating for the company in a report on Wednesday, October 30th. Barclays upped their price objective on shares of MSCI from $650.00 to $700.00 and gave the company an “overweight” rating in a research note on Friday, September 13th. Evercore ISI initiated coverage on shares of MSCI in a research report on Wednesday, October 2nd. They set an “outperform” rating and a $690.00 target price on the stock. Finally, Redburn Atlantic upgraded MSCI from a “neutral” rating to a “buy” rating and set a $680.00 price target for the company in a report on Wednesday, October 9th. Seven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $631.83.
View Our Latest Report on MSCI
MSCI Profile
MSCI Inc, together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.
Featured Stories
- Five stocks we like better than MSCI
- What is a Death Cross in Stocks?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing In Preferred Stock vs. Common Stock
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- There Are Different Types of Stock To Invest In
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for MSCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI and related companies with MarketBeat.com's FREE daily email newsletter.